Sarossa Capital sarossaplc.com


Sarossa, formerly Antisoma, is an investment holding and management company whose principal activity is investment in and growth and development of businesses which present opportunities for value creation.

Sarossa, formerly Antisoma, is an investment holding and management company whose principal activity is investment in and growth and development of businesses which present opportunities for value creation.

Company (Acquired)

Phone:

Fax: +44 (0)20 3249 2101

17 The Esplanade
St. Helier
Jersey, JE1 1WT
England, United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Sarossa Capital $1.4M Feb 8, 2005
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Sarossa Capital Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

HNC Software

Fallbrook, California, United States
AcquiredHNC Software is a provider of Customer Insight software that enables companies to acquire, manage and retain customers. HNC's decision management and customer analytics technology analyze both structured and unstructured data so companies can derive value from all information. The company's sophisticated software is used in the telecommunications, financial services, insurance and e-commerce industries.Login to see details

Threshold Pharmaceuticals

Redwood City, California, United States
MergedThreshold Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of small molecule therapeutics based on Metabolic Targeting, an approach that offers broad potential to treat most solid tumors and certain other diseases. By selectively targeting tumor and certain other diseased cells, Threshold's pipeline of drug candidates holds promise to be more effective and less toxic to healthy tissues than conventional drugs. Threshold's initial clinical foc...Show allLogin to see details
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)